Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...

Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the ...

This represents Alector's second failed neurodegenerative asset in a year, after an AbbVie-partnered asset missed in ...

Advanced MRI detects early frontotemporal dementia microstructural damage, enabling earlier diagnosis and monitoring of disease progression.

Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; ...

In the wake of Bruce Willis' diagnosis, Emma Heming has taken to social media to raise awareness about FTD, a type of dementia that affects behavior, personality, and language. Through her heartfelt ...

An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...

A research registry tracking data on a particular form of dementia will be created under a new law sponsored by state Sen.

A new international study led by researchers at Karolinska Institutet demonstrates that it is possible to detect subtle ...

At least one psychologist is convinced that President Donald Trump has dementia. Dr. John Gartner told The Daily Beast ...